Short term results of vaccination with adjuvanted recombinant varicella zoster glycoprotein E during initial BTK inhibitor therapy for CLL or lymphoplasmacytic lymphoma

Authors

• Zent, Clive S.¹
• Brady, Michael T.¹
• Delage, Carolyne¹
• Strawderman, Myla¹
• Laniewski, Nathan¹
• Contant, Phuong N.¹
• Kanagaiah, Preshetha¹
• Sangster, Mark Y.¹
• Barr, Paul M.¹
• Chu, Charles C.¹
• Topham, David J.¹
• Friedberg, Jonathan W.¹

• ¹ University of Rochester Medical Center,

Type

Published Article

Journal

Leukemia

Publisher

Springer Nature

Publication Date

Oct 30, 2020

Pages

1–4

Identifiers

DOI: 10.1038/s41375-020-01074-4

PMID: 33128020

PMCID: PMC7596619

Source

PubMed Central

Keywords

• Chronic Lymphocytic Leukaemia
• Drug Development

License

Unknown